HOLOCENE ADVISORS, LP Intra-Cellular Therapies, Inc. Transaction History

HOLOCENE ADVISORS, LP portfolio value:

$74.04M
portfolio value

HOLOCENE ADVISORS, LP quarter portfolio value change:

-18.48%
quarter

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -2.21% -36.02K shares -18.84M $46.53 1.59M
Q2 2022 share Increase +125.18% 904.68K shares 48.66M $57.08 1.62M
Q1 2022 share Increase 0.00% 722.72K shares 44.22M $61.19 722.72K